SCHEDULE 13D/AAccepted Apr 16, 4:15 PM ET
Tvardi Therapeutics, Inc. SCHEDULE 13D/A
Accepted (ET)
4:15 PM
Apr 16, 2025
Filed
Apr 16, 2025
Documents
1
Size
11.0 KB
Summary
Summary not available
This filing does not have a written summary yet. You can still open the original filing and its exhibits.